UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 676

Sortiert nach

Molecular Stratification of Triple‐Negative Breast Cancers

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (S1), p.61-70

Perou, Charles M.

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular Stratification of Triple‐Negative Breast Cancers

The oncologist (Dayton, Ohio), 2010-11, Vol.15 (S5), p.39-48

Perou, Charles M.

2010

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

Breast cancer research : BCR, 2010-09, Vol.12 (5), p.R68-R68, Article R68

2010

Link zum Volltext

Verfügbarkeit prüfen

SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references

Briefings in bioinformatics, 2021-01, Vol.22 (1), p.416-427

2021

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling

BMC genomics, 2014-06, Vol.15 (1), p.419-419, Article 419

2014

Link zum Volltext

Verfügbarkeit prüfen

The genomic landscape of breast cancer as a therapeutic roadmap

Cancer discovery, 2013-01, Vol.3 (1), p.27-34

2013

Link zum Volltext

Verfügbarkeit prüfen

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer

Nature genetics, 2014-10, Vol.46 (10), p.1051-1059

2014

Link zum Volltext

Verfügbarkeit prüfen

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

PloS one, 2012-05, Vol.7 (5), p.e36530-e36530

2012

Link zum Volltext

Verfügbarkeit prüfen

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Radiology, 2016-11, Vol.281 (2), p.382

2016

Link zum Volltext

Verfügbarkeit prüfen

Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

Cell reports (Cambridge), 2015-12, Vol.13 (11), p.2353-2361

2015

Link zum Volltext

Verfügbarkeit prüfen

Practical implications of gene-expression-based assays for breast oncologists

Nature reviews. Clinical oncology, 2012-01, Vol.9 (1), p.48-57

2012

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2013-02, Vol.18 (2), p.123-133

2013

Link zum Volltext

Verfügbarkeit prüfen

Mammary development meets cancer genomics

Nature medicine, 2009-08, Vol.15 (8), p.842-844

2009

Link zum Volltext

Verfügbarkeit prüfen

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

JNCI : Journal of the National Cancer Institute, 2016-11, Vol.108 (11), p.djw144

2016

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Archives of pathology & laboratory medicine (1976), 2020-05, Vol.144 (5), p.545-563

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Journal of clinical oncology, 2013-01, Vol.31 (2), p.203-209

2013

Link zum Volltext

Verfügbarkeit prüfen

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

BMC genomics, 2011-01, Vol.4 (1), p.3-3, Article 3

2011

Link zum Volltext

Verfügbarkeit prüfen

Improved indel detection in DNA and RNA via realignment with ABRA2

Bioinformatics (Oxford, England), 2019-09, Vol.35 (17), p.2966-2973

2019

Link zum Volltext

Verfügbarkeit prüfen

GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

Nature communications, 2018-03, Vol.9 (1), p.1059-14, Article 1059

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1168-1176

2009

Link zum Volltext

Verfügbarkeit prüfen

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Cell, 2019-11, Vol.179 (5), p.1191-1206.e21

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer

PloS one, 2013-05, Vol.8 (5), p.e61359

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 676

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(661)
Mit Volltextzugriff
(634)

Publikationsform

Sprache

Englisch
(675)
Japanisch
(168)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(425)
Humans
(370)
Life Sciences & Biomedicine
(369)
Female
(283)
Oncology
(227)
Breast Cancer
(209)
Breast Neoplasms - Genetics
(172)
Tumors
(172)
Gene Expression
(143)
Breast Neoplasms - Pathology
(130)
Animals
(111)
Mice
(96)
Cancer
(94)
Middle Aged
(91)
Biological And Medical Sciences
(88)
Gene Expression Profiling
(88)
Breast Neoplasms - Drug Therapy
(79)
Breast Neoplasms - Metabolism
(79)
Gene Expression Regulation, Neoplastic
(78)
Prognosis
(76)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Molecular Stratification of Triple‐Negative Breast Cancers

Molecular Stratification of Triple‐Negative Breast Cancers

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)

Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

The genomic landscape of breast cancer as a therapeutic roadmap

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents

Practical implications of gene-expression-based assays for breast oncologists

Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast Cancer

Mammary development meets cancer genomics

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

Improved indel detection in DNA and RNA via realignment with ABRA2

GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer

Suchergebnisse filtern